Cancer Vaccine Week articles from October 2008

Cancer Vaccine Week archives from October 2008

Research from College of Medicine provide new insights into cancer vaccines.
October 6, 2008... "New therapies are needed that target breast cancer metastases. In previous studies, we have shown that vaccination with pcDNA3.1-Mage-b DNA vaccine is effective against breast cancer metastases," researchers in the United States report (see...

New vaccines research has been reported by scientists at National Institutes of Health.(Report)
October 6, 2008... According to a study from the United States, "Carbohydrate-protein conjugates are utilized extensively in basic research and as immunogens in a variety of bacterial vaccines and cancer vaccines. As a result, there have been significant efforts...

Studies from Tokai University add new findings in the area of vaccines.
October 6, 2008... "In the present study, the adjuvant capacity of oligomannose-coated liposomes (OMLs) was evaluated in mice, and an OML-based vaccine was shown to induce effective anti-tumor immunity. C57BL/6 mice were immunized subcutaneously with OML-encased...

Research results from University of Duisburg-Essen update understanding of women's health.(Clinical report)
October 6, 2008... "The availability of vaccines against certain HPV types and the development of broad spectrum genotyping methods have increased interest in co-infections with different HPV types. In the present study, the prevalence and type-specific...

Data on cancer vaccines described by researchers at Center of Molecular Immunology.
October 6, 2008... Investigators publish new data in the report 'Priming and boosting determinants on the antibody response to an Epidermal Growth Factor-based cancer vaccine.' "Epidermal Growth Factor chemically conjugated to P64k carrier protein from Neisseria...

Researchers from Copenhagen University, Oncology Center describe findings in cancer vaccines.
October 6, 2008... Current study results from the report, 'Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2,' have been published. "We...

Researchers from Oregon Health & Science University detail findings in cancer vaccines epidemiology.
October 6, 2008... A new study, 'Regional differences in cervical cancer incidence among American Indians and Alaska Natives, 1999-2004,' is now available. According to a study from the United States, "Reports from limited geographic regions indicate higher rates...

Researchers from Fred Hutchinson Cancer Research Center publish findings in cancer vaccines immunology.(Clinical report)
October 6, 2008... New investigation results, 'Translational Research Working Group developmental pathway for immune response modifiers,' are detailed in a study published in Clinical Cancer Research. According to recent research from the United States, "The...

Reports by M. Lidqvist and co-researchers describe recent advances in human papillomavirus vaccines.(Report)
October 6, 2008... New research, 'Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies,' is the subject of a report. According to recent research from Gothenburg, Sweden, "The paper...

Data on life sciences discussed by researchers at Memorial Sloan Kettering Cancer Center.
October 6, 2008... A report, 'Evaluation of widely consumed botanicals as immunological adjuvants,' is newly published data in Vaccine. According to a study from the United States, "Many widely used botanical medicines are claimed to be immune enhancers. Clear...

Recent studies by R. Herrero and co-authors add new data to pelvic exam findings.(Report)
October 6, 2008... Research findings, 'Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica,' are discussed in a new report. "We report the rationale, design, methods and details of...

Luminex and BD Sign Agreement to Create Diagnostic Tests for Cancer; Collaboration Will Target New Tools to Enhance Early Cancer Detection and Intervention.
October 6, 2008... Luminex Corporation (NASDAQ: LMNX), a worldwide leader in multiplexed solutions, and global medical technology company BD (NYSE: BDX), through its BD Diagnostics-TriPath platform, announced the signing of a development and supply agreement....

US Rep Gregory Meeks to Give Opening Remarks to African American Prostate Cancer Survivors.
October 6, 2008... The Fourth Annual African American Prostate Cancer Disparity Summit, hosted by the Prostate Health Education Network (PHEN) and supported by Congressman Gregory W. Meeks aims to confront the current disparity leaving black men dying at more...

Wistar Institute Researcher Receives New Innovator Award from NIH.
October 6, 2008... A Wistar Institute researcher's novel approach to understanding genetic causes of human disease has earned him an NIH Director's New Innovator Award and grant from the National Institutes of Health. Ken-ichi Noma, Ph.D., an assistant...

ImmunoCellular Therapeutics Elects Dr. James Bender to Position of Vice President, Clinical Development.
October 6, 2008... ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC) (IMUC), a biotechnology company, announced that it has elected James G. Bender, Ph.D., M.P.H., to the position of vice president, clinical development. Dr. Bender joins the company from...

Quarterly Netherlands Pharmaceuticals and Healthcare Report - Q3 2008.
October 6, 2008... Research and Markets (http://www.researchandmarkets.com/research/1ab86e/netherlands_pharma) has announced the addition of the "Netherlands Pharmaceuticals and Healthcare Report Q3 2008" report to their offering (see also Research and Markets...

Hepatitis B exposure may increase risk for pancreatic cancer.
October 13, 2008... In a first-of-its-kind finding, researchers at The University of Texas M. D. Anderson Cancer Center have discovered that exposure to the hepatitis B virus (HBV) may increase the risk of pancreatic cancer (see also University of Texas M. D....

Data on cancer vaccines reported by S.W. Howland and co-researchers.
October 13, 2008... "Saccharomlyces cerevisiae Stimulates dendritic cells (DCs) and represents a promising candidate for cancer vaccine development. Effective cross-presentation of antigen delivered to DCs is necessary for Successful induction of cellular...

Recent findings from W.H. Shingler and co-authors highlight research in cancer vaccines.
October 13, 2008... "The cancer vaccine TroVax, modified vaccinia Ankara encoding the tumor-associated antigen 5T4, has been tested in phase I and II studies in colorectal cancer patients. Monitoring of 5T4-specific immune responses in patients receiving TroVax is...

Reports from Stanford University describe recent advances in cancer vaccines.
October 13, 2008... "Plant-made vaccines have been the subject of intense interest because they can be produced economically in large scale without the use of animal-derived components. Plant-made therapeutic vaccines against challenging chronic diseases, such as...

Reports on cancer vaccines findings from Vanderbilt University provide new insights.
October 13, 2008... "HPV is the most common sexually transmitted infection in the world. While most strains are relatively harmless, some increase a woman's risk of developing cervical cancer," investigators in the United States report (see also Cancer Vaccines)....

Peking Union Medical College details research in cancer vaccines.
October 13, 2008... A report, 'Enhanced anti-tumor immunity generated by Rituximab-coated tumor cell vaccine,' is newly published data in Cancer Letters. "Rituximab is a chimeric monoclonal antibody against CD20, and has been used to treat malignant tumors derived...

Researchers from University of North Carolina report on findings in cancer vaccines.
October 13, 2008... Researchers detail in 'Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer,' new data in cancer. "Potential barriers to widespread vaccination of adolescent girls against human...

University of California, Division of Adolescent Medicine publishes research in cancer vaccines.(Report)
October 13, 2008... Research findings, 'HPV Vaccines: today and in the Future,' are discussed in a new report. According to a study from the United States, "Human papillomavirus (HPV) is responsible for 99.7% of cervical cancer cases and an estimated 5% of all...

Researchers from University of North Carolina, Department of Epidemiology discuss findings in human papillomavirus risk factors.
October 13, 2008... New investigation results, 'Age-specific prevalence of infection with human papillomavirus in females: a global review,' are detailed in a study published in Journal of Adolescent Health. "Global data on age-specific prevalence of human...

Study finds association between hepatitis B and pancreatic cancer.(Report)
October 13, 2008... Hepatitis B could be a risk factor for pancreatic cancer A new study has shown that evidence of past hepatitis B infection was twice as common in people with pancreatic cancer than in healthy controls. This study is the first to report an...

FDA Grants Permission for Export of Antigenics' Oncophage to Russia.
October 13, 2008... Antigenics Inc. (NASDAQ: AGEN) announced that the U.S. Food and Drug Administration (FDA) has granted the necessary permission to allow for the export of Oncophage (R) (vitespen) to Russia (see also Antigenics Inc.). The Russian Ministry...

AVANT Immunotherapeutics Announces Name Change to Celldex Therapeutics.
October 13, 2008... AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) (the "Company"), announced that, pursuant to a previously announced shareholder vote, the Company will change its name to Celldex Therapeutics, Inc. effective October 1, 2008 and shares of the...

Bayer Broadens Its Manufacturing Basis for Biopharmaceuticals in Tobacco Plants.
October 13, 2008... Bayer Innovation GmbH and Kentucky Bioprocessing, LLC (KBP) are collaborating to develop a facility at KBP's Owensboro plant in the US state of Kentucky for the production service of biopharmaceuticals. Based on Bayer's proprietary magnICON(R)...

$1 Million Donation from GlaxoSmithKline to Help Patients with Cancer and Their Families at Children's Hospital of Philadelphia.
October 13, 2008... Children's Hospital of Philadelphia is delighted to announce a $1 million gift from GlaxoSmithKline. This donation will be matched by Children's Hospital to create the GlaxoSmithKline Hope for Families Fund, a permanent endowment that will help...

ImmunoVaccine Technologies' DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases.
October 13, 2008... ImmunoVaccine Technologies' (IVT) patented depot vaccine formulation, DepoVax(TM) is showing positive pre-clinical results, with single-dose efficacy achieved in therapeutic cancer and several infectious disease vaccine models. The results of...

MaxCyte and Medinet to Present at the 10th International Symposium on Dendritic Cells in Kobe, Japan.(Clinical report)
October 13, 2008... MaxCyte, Inc. and Medinet Co., Ltd. announce a joint poster presentation at The 10th International Symposium on Dendritic Cells. The meeting is being held October 1-5, 2008 in Kobe, Japan (see also Cancer Vaccines). The presentation is...

Idera Pharmaceuticals Announces Preliminary Data from Phase 2a Clinical Study of IMO-2055 Monotherapy in Renal Cell Carcinoma.(Clinical report)
October 13, 2008... Idera Pharmaceuticals, Inc. (Nasdaq: IDRA), announced preliminary data from the first part of a Phase 2 clinical study conducted by the Company of IMO-2055 monotherapy in patients with metastatic or recurrent clear cell renal carcinoma (RCC)....

ImmunoVaccine Technologies' DepoVax Shows Positive Results for Cancer and Infectious Diseases.
October 13, 2008... ImmunoVaccine Technologies' (IVT) patented depot vaccine formulation, DepoVax(TM) is showing positive pre-clinical results, with single-dose efficacy achieved in therapeutic cancer and several infectious disease vaccine models. The results...

Telormedix Raises 21 Mio CHF in Series a Financing.
October 13, 2008... Telormedix SA, a leader in novel immunotherapeutic molecules, has announced the closing of its first Series A equity investment round raising 21 Mio CHF (EUR 13.1 million, $19 million), one of the largest Series A round in Switzerland for a...

Data on cancer vaccines discussed by Y.H. Li and colleagues.
October 20, 2008... "Cross-presentation of antigens is critical for the induction of adaptive immunity against tumor cells and infectious pathogens. Currently, it is not known how cross-presentation of tumor antigens is regulated by autophagy," investigators in...

Findings from T. Tsuruma and co-authors broaden understanding of cancer vaccines.(Clinical report)
October 20, 2008... "We previously reported that survivin-2B, a splicing variant of survivin, was expressed in various types of tumors and that survivin-2B peptide might serve as a potent immunogenic cancer vaccine. The objective of this study was to examine the...

Research in the area of cancer vaccines reported from Kyushu University.
October 20, 2008... "We previously showed that a combination therapy with tumor cell-pulsed monocyte-derived dendritic cells (DCs) and activated lymphocytes was well tolerated in patients with disseminated carcinomas. Recently, accumulating evidence has indicated...

Researchers from Baylor College of Medicine, College of Medicine provide details of new studies and findings in the area of cancer vaccines.
October 20, 2008... According to a study from the United States, "The cancer testis antigen (CTA) preferentially expressed antigen of melanoma (PRAME) is overexpressed in many hematologic malignancies, including chronic myeloid leukemia (CML). The sensitivity of...

Researchers from Southampton University, Cancer Sciences Division report on findings in cancer vaccines.
October 20, 2008... Researchers detail in 'Optimising anti-tumour CD8 T-cell responses using combinations of immunomodulatory antibodies,' new data in cancer. "Immunostimulatory mAb as vaccine adjuvants for the treatment of cancer hold considerable potential for...

Researchers from University of Tennessee, Department of Family Medicine detail findings in cancer vaccines.(Report)
October 20, 2008... A new study, 'Human papillomavirus vaccination coverage on YouTube,' is now available. According to a study from the United States, "A large percentage of Internet users regularly search for health-related information. In recent years,...

Researchers from Tarbiat Modares University, Department of Virology discuss findings in human papillomavirus vaccines.
October 20, 2008... New investigation results, 'Isolation and cloning of human papillomavirus 16 L1 gene from Iranian isolate,' are detailed in a study published in Saudi Medical Journal. "To isolate and construct cloning and expression vectors containing human...

Advaxis Chief Executive Officer to Present at the 10th Annual World Vaccine Congress.
October 20, 2008... Advaxis Incorporated (OTCBB: ADXS) Chairman and CEO Tom Moore will present at this year's World Vaccine Congress 2008, being hosted at Le Palais des Congres de Lyon in Lyon, France. The Conference will be held October 6 - 9, 2008 (see also...

BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine.
October 20, 2008... BN ImmunoTherapeutics has now evaluated the mature Phase II data from the therapeutic prostate cancer vaccine candidate PROSTVAC(TM) that had been obtained as part of the recently entered partnership with the National Cancer Institute (NCI) in...

Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention.
October 20, 2008... The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies -- such as HPV testing and HPV vaccines -- that are helping to eradicate cervical cancer...

UNC Charlotte to Evaluate Potential Adjuvant Activity of ImmuneRegens Viprovex[R] with Cancer Vaccine.
October 20, 2008... ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB:IRBS), announced a collaborative relationship with the University of North Carolina at Charlotte to evaluate ImmuneRegen's Viprovex as a possible...

Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months.
October 20, 2008... Vical Incorporated (NASDAQ:VICL) today is presenting expanded clinical data and new nonclinical data demonstrating that the company's Vaxfectin(R) adjuvant may be broadly applicable in DNA- and protein-based infectious disease vaccines and...

Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children.(Website overview)
October 20, 2008... From asthma and cancer treatments to vaccines, research in children saves lives and improves their health and well-being. A new Web site from the National Institutes of Health (NIH), "Children and Clinical Studies"...

Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR.
October 20, 2008... Nventa Biopharmaceuticals Corporation (TSX: NVN), a company developing innovative therapeutics for the treatment of viral infections and cancer, today provided an update on its ongoing development programs. The company also announced that it...

ImmunoCellular Therapeutics Announces Filing of Patent Application for a Novel Cancer Stem Cell Vaccine Technology.
October 20, 2008... ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (IMUC), a biotechnology company, announced the filing of a provisional U.S. patent application relating to its novel vaccine technology targeting cancer stem cells. The vaccine technology is...

Get a Jump on the Flu Season at Your Neighborhood Ralphs and Food 4 Less Pharmacy.
October 20, 2008... Now that summer is over, it's time to start preparing for cooler weather and the potential flu season by getting vaccinated against the influenza virus at your neighborhood Ralphs and Food 4 Less Pharmacies (see also Influenza). Ralphs and...

Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center.
October 20, 2008... Oncologists at the Moores Cancer Center at the University of California, San Diego (UCSD) in La Jolla are hoping to stave off the relentless march of advanced lung cancer by treating patients with a novel kind of cancer vaccine. While many...

Studies from University of Saskatchewan add new findings in the area of cancer gene therapy.(Report)
October 27, 2008... According to recent research published in the journal Cancer Gene Therapy, "HER-2/neu transgene-modified dendritic cell (DC)-based vaccines are potent at eliciting HER-2/neu-specific antitumor immunity. In this study, we constructed a...

Data on cancer vaccines described by S. Kang et al.(Clinical report)
October 27, 2008... According to recent research from Seoul, South Korea, "Human papillomavirus (HPV) is a major causative agent of anogenital warts and a necessary cause of cervical cancer. This report will serve to assess the safety and immunogenicity of...

Reports summarize cancer vaccines research from Q. Zhou and co-authors.(Report)
October 27, 2008... According to a study from Guangzhou, People's Republic of China, "XAGE-1b is regarded as one of the most immunogenic antigens and the most promising targets for lung adenocarcinoma immunotherapy. In this study, we sought to determine whether...

Research from R. Hanisch and co-researchers in the area of cancer vaccines described.(Report)
October 27, 2008... According to recent research from Medellin, Colombia, "This study evaluated Pap screening and human papillomavirus (HPV) knowledge in a population of Colombian women as a possible contributing factor of low cervical cancer screening success....

Studies by A. Demachiokamura and co-authors describe new findings in cancer vaccines.
October 27, 2008... According to recent research published in the journal Cancer Science, "Epstein-Barr virus (EBV) nuclear antigen (EBNA)1 is expressed in every EBV-infected cell, regardless of the state of EBV infection. Although EBNA1 is thought to be a...

New helicobacter pylori findings from Novartis published.(Clinical report)
October 27, 2008... "Helicobacter pylori infection is among the most common human infections and the major risk factor for peptic disease and gastric cancer. Immunization with vaccines containing the H pylori vacuolating cytotoxin A (VacA), cytotoxin-associated...

New immunotherapy findings from Third Military Medical University described.
October 27, 2008... "Peptide vaccination for cancer immunotherapy requires identification of peptide epitopes derived from antigenic proteins associated with tumors. Heparanase (Hpa) is broadly expressed in various advanced tumors and seems to be an attractive new...

Research data from University of Leipzig update understanding of life sciences.
October 27, 2008... According to a study from Leipzig, Germany, "Therapeutic effects of haematopoietic stem cell transplantation are not limited to maximal chemoradiotherapy and subsequent bone marrow regeneration, but include specific as well as unspecific immune...

Study results from McMaster University broaden understanding of vaccines.
October 27, 2008... According to recent research from Hamilton, Canada, "In vitro manipulated dendritic cells (DC have increasingly been used as a promising vaccine formulation against cancer and infectious disease. However, improved understanding of the immune...

Data on cancer vaccines described by researchers at Naval Medical Center.
October 27, 2008... Investigators publish new data in the report 'Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.' "E75, a...

Data on cancer vaccines detailed by researchers at University of New Mexico, Health Science Center.(Report)
October 27, 2008... New research, 'Preventing cervical cancer: the Pap test and the HPV vaccine,' is the subject of a report. According to recent research from the United States, "Women look to their internists and other primary care physicians to provide...

Data on cancer vaccines reported by researchers at Center of Molecular Immunology.
October 27, 2008... Fresh data on cancer are presented in the report 'Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine.' "Up to now clinical experiences focusing EGF receptor, an...

Researchers from Epeius Biotechnologies Corporation detail findings in cancer vaccines.
October 27, 2008... A new study, 'Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ,' is now available. According to a study from San Marino, "The advent of pathotropic...

Data on gene therapy discussed by investigators at German Cancer Research Center, Division of Cellular Immunology.
October 27, 2008... A report, 'Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2,' is newly published data in International Journal of Oncology. According to a study from Heidelberg, Germany, "A new...

Data on influenza therapy published by researchers at University of St. Andrews, Center for Biomolecular Sciences.
October 27, 2008... Data detailed in 'The multifunctional NS1 protein of influenza A viruses' have been presented. According to recent research published in the Journal of General Virology, "The non-structural (NS1) protein of influenza A viruses is a...

Antigen-Carrying Bacteria Prime Immune System Against Melanoma.
October 27, 2008... Therapeutic cancer vaccines, while still mostly in early development, are one of the more promising developments in medicine today. A study published in the October 1, 2008 edition of the journal Cancer Research reports some of the most...

RNCOS Releases a New Report- Global Vaccine Market Forecast to 2012.
October 27, 2008... RNCOS has recently added a new Market Research Report titled, "Global Vaccine Market Forecast to 2012" to its report gallery. The report states that vaccines, which were earlier thought as a low margin, low growth industry, have emerged as one...